Feiba | Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Adverse Reactions

Adverse Reactions From Clinical Trials: The adverse reactions presented in this section have been reported from 2 studies with FEIBA for the treatment of bleeding episodes in pediatric and adult patients with hemophilia A or B and inhibitors to factors VIII or IX. One study also enrolled acquired hemophilia patients with factor VIII inhibitors (2 of 49 patients). (See Table 2.)

Click on icon to see table/diagram/image

Post-marketing Adverse Reactions: The following adverse reactions have been reported in the post-marketing experience.
BLOOD AND LYMPHATIC SYSTEM DISORDERS: Disseminated intravascular coagulation.
IMMUNE SYSTEM DISORDERS: Anaphylactic reaction.
NERVOUS SYSTEM DISORDERS: Paresthesia, Thrombotic stroke, Embolic stroke.
CARDIAC DISORDERS: Myocardial infarction, Tachycardia.
VASCULAR DISORDERS: Thrombosis, Venous thrombosis, Arterial thrombosis, Hypertension, Flushing.
RESPIRATORY, THORACIC, AND MEDIASTINAL DISORDERS: Pulmonary embolism, Bronchospasm, Wheezing, Cough.
GASTROINTESTINAL DISORDERS: Vomiting, Diarrhea, Abdominal discomfort.
SKIN AND SUBCUTANEOUS TISSUE DISORDERS: Angioedema, Urticaria, Pruritus.
GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS: Malaise, Feeling hot, Injection site pain.

View ADR Reporting Link

Feiba Adverse Reactions

Manufacturer:

Takeda

Distributor:

Zuellig Pharma